Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Model structure.

More »

Fig 1 Expand

Table 1.

Model parameters.

More »

Table 1 Expand

Table 2.

Cost-utility analysis results classified by hepatitis A inactivated vaccine strategies and perspective among individuals aged 15 years.

More »

Table 2 Expand

Table 3.

Cost-utility analysis results classified by hepatitis A inactivated vaccine strategies and perspective among children aged 1 year.

More »

Table 3 Expand

Fig 2.

Cost-effectiveness plane by a societal perspective A) among 15 years receiving inactivated hepatitis A vaccination without screening strategy B) among 15 years with screening and inactivated hepatitis A vaccination C) Child aged 1 year receiving inactivated hepatitis A vaccination.

More »

Fig 2 Expand

Fig 3.

Cost-effectiveness acceptability curve by a societal perspective.

A) among 15 years receiving inactivated hepatitis A vaccination without screening strategy B) among 15 years with screening and inactivated hepatitis A vaccination C) Child aged 1 year receiving inactivated hepatitis A vaccination.

More »

Fig 3 Expand

Table 4.

Budget impact analysis for hepatitis A vaccination strategy among individuals aged 15 years and children aged 1 year (million ₹).

More »

Table 4 Expand